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Abstract 
Background: Burkitt’s lymphoma is a high grade B-cell neoplasm, which is a kind of small non-cleaved cell 
lymphoma. It is presumably the fastest growing human malignancy, and the patients are prone to develop tumor-
lysis syndrome. Here we present findings on our patients with Burkitt lymphoma.  
Materials and Methods: This descriptive retrospective study included 46 children with abdominal Burkitt's 
lymphoma who were treated during 15 years from June 1998 to Dec 2013 at Mofid Children’s Hospital.  
Results: Offourty six patients 32 (70%) were boys and 14 (30%) were girls with ages ranging from 2 to 14 years. 
Surgical exploration was carried out in all cases, the lesions were located in the small intestine (N=17), large 
intestine (N=15), ileocecal region (N=12), and stomach (N=2). We performed a complete mass resection in 16 
cases, debulking in 10 and lymph node/mass biopsy in 20 cases. Pathologic examination revealed Burkitt’s 
lymphoma for all patients. The majority were stageIIE and stage IIIE (24 and 19 respectively). Post-operative 
complications were seen in five cases with the most common being persistent ileus. All patients received a sort of 
systemic chemotherapy. The mean follow up duration was 6 years. Death occurred in 7(15%) of our patients, due to 
tumor lysis syndrome and acute renal failure. 
Conclusion: The extent ofdisease at presentation is the most important prognostic factor in abdominal Burkitt’s 
lymphoma. Children with BL are at a high risk of tumor lysis syndrome before or during chemotherapy. Surgery 
still plays an important role in this pathology, and chemotherapy offers an excellent chance for long term disease 
free survival. 
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Introduction  
Lymphoma is the third most common 
childhood malignancy which accounts for 
approximately 7% of pediatric oncology 
patients. Non-hodgkin lymphoma (NHL) is 
commonly classified into three categories: 
(1) B-cell (NHL include Burkitt’s and 
Burkitt-like lymphoma, and diffuse large B-
cell lymphoma), (2) lymphoblastic 
lymphoma (primarily precursor T-cell 
Lymphoma and less frequently precursor B-
cell lymphoma)  and (3) Anaplastic large 
cell lymphoma (T-cell or nul cell 
lymphoma).
1,2,3
Burkitt’s lymphoma (BL) is 
highly aggressive, rapidly growing B-cell 
neoplasm mainly affecting children and 
young adults, that are characterized by 
dysregulation of  the C-myc oncogene.
4 
BL is a high grade B-cell neoplasm under 
the umbrella of non-Hodgkin’s lymphoma. 
There exist three major clinical types: 
Endemic form which is a common 
childhood malignancy strongly associated 
with the Epstein-Barr virus (EBV), The non-
endemic (sporadic) form which is rare and 
the immunodeficiency-related BL, almost 
often seen in AIDS patients; the  sporadic 
form typically presents as extra nodal 
disease.
5
 BL is a progressive disease 
primarily treated with intensive 
chemotherapy therefore the presence of 
sepsis or any other condition, that delays 
chemotherapy, will have a bad effect on the  
prognosis. Thus, it is of importance to 
diagnose the disease before complications 
occur and initiate treatment immediately.
5
 
There are two potentially life-threatening 
conditions that are often seen in children 
with NHL: (1) Pressure effect on vital 
organs such as mediastinal tumor which 





could result in major airway obstruction, this 
condition is more prevalent in lymphoblastic 
lymphoma, and (2)Tumor lysis syndrome, 
most often seen in lymphoblastic and 
Burkitt or Burkitt-like NHL.
1
   In this 
article, we will focus on the management of 
patients with Burkitt’s lymphoma.  
Material and methods 
In a descriptive retrospective study, 46 
children with intra-abdominal Burkitt’s 
lymphoma whom have been operated on, in 
Mofid children’s Hospital from June 1998 to 
Dec 2013 were evaluated. A complete 
preoperative work-up was done in all cases 
which included complete blood count, 
urinalysis, biochemical analysis, and 
imaging studies, Bone marrow and 
cerebrospinal fluid (CSF) examinations 
were also added except in urgent cases.  
Localized disease was defined as limited to 
one anatomic area and adjacent mesenteric 
lymph nodes, and disseminated disease was 
defined as a tumor which extended beyond 
the primary site or when metastasis existed. 
All patients underwent laparotomy and the 
surgical procedure was classified as total 
excision, debulking or incisional biopsy. 
Laparotomy was performed in all patients. 
16 cases underwent emergency surgery 
because of acute abdomen, and others were 
referred with the symptoms of abdominal 
mass, pain, anorexia, and weight loss. After 
completing laboratory and radiological 
studies, all of them underwent elective 
surgery with the pre-diagnosis of abdominal 
malignant tumor. All had chemotherapy 
consisting of a combination of 
cyclophosphamide, vincristine, 
prednisolone, prednisone, and adriamycine 
post-operatively, which was repeated every 
4 weeks. All were checked by abdominal 
and thoracic Ct-scan and CSF analysis 
during and post-chemotherapy periods if 
needed. Collected data from the patient’s 
medical records were analyzed and variables 
such as age, gender, diagnostic tools, tumor 
localization, surgical and medical treatment 
and outcome were evaluated.  
Results 
The patients consisted of 32 (70%) boys, 
and 14 (30%) girls, with ages ranging from 
2 to 14 years. Table 1 shows the presenting 
symptoms of the patients. Abdominal pain 
was the most common symptom which was 
present in 38(83%), followed by abdominal 
swelling which was present in 30 (65%) 
patients. In 16 cases the pathology was 
established preoperatively by endoscopy or 
ultrasound or CT guided biopsy, while in 30 
cases exploration was done based on 
radiological and clinical data only. The aim 
of surgery was to establish the diagnosis, 
evaluate the disease extent and remove the 
whole lesion if possible or take biopsy. The 
tumors were located in small intestine 
(N=17), large intestine (N=15), ileocecal 
(N=12), and stomach (N=2) andtable 2 
shows the site of the disease in all the 46 
patients. Complete mass resection was 
performed in 16 (35%) cases, debulking in 
10 (22%), and lymph node/mass biopsy in 
20 (43%). Five patients (11%) had extensive 
intra-abdominal Tumor, and tumors were 
fixed and had liver, or kidney metastases. 
Pathology examination revealed Burkitt 
lymphoma for all patients. The majorities 
were stage IIE and stage IIIE (24 and 19 
respectively); only three patients had stage 
IVE disease. Post-operative complications 
occurred in five cases with the most 
common being persistent ileus,followed by 
blood loss more than 250cc, wound 
dehiscence, and subhepatic abscess which 
required CT guided drainage. All patients 
received a sort of systemic chemotherapy 
and the response to chemotherapy was 
collectively reported as complete remission 





in 39 patients (85%), tumor regression in 3 
(7%) and disease progression in 6 (13%). 
 All 16 patients with localized tumor are 
alive after a mean follow up duration of six 
years (survival rate=100%). Mortality in the 
debunking group was 3 (30%) cases due to 
tumor lysis syndrome and acute renal 
failure, but the other 7 cases are alive 
(survival rate=70%).  
 Of the 20 patients in the biopsy group, 4  
were lost to follow up during chemotherapy  
regimens (tumor lysis 2, CNS involvement 
1, post chemotherapy sepsis 1), the 
remaining 16 are alive with a mean follow 
up duration of 6 years (survival rate = 80%). 
Second look operation was performed in 
patients of our biopsy group due to residual 
tumors. Survival rate in all 3 groups are 
shown in table 3.  
 
Table 1: Presenting symptoms in the study group 
Table 2: Shows the site of the disease in our 46 patients. 
Table 3: Initial surgical procedure and survival 
Abdominal 
tumor type 
Procedure type  Patients No Mortality Survival (%) 
Localized 
Total resection 16 0 100 
Disseminated 
Debulking 10 3 70 
Biopsy 20 4 80 
      Total   - 46 7 - 
 
Symptom  Number  Percent  
Abdominal pain 38 85 
Abdominal swelling 30 65 
Vomiting 16 35 
Intestinal obstruction 16 35 
Constipation 12 26 
Diarrhea 5 11 
Melena 5 11 
Bleeding per rectum 4 9 
Site Number  Percent  
Stomach      2 4 
Small bowel 17 37 
Large bowel 
   RT Colon 







Small and large bowel 
(All in the ileocecal region) 
12 26 






Burkitt's lymphoma occurs more frequently 
in children than in adults with male to 
female ratio of 2.5:1
6
.In our series this ratio 
was 3:1. The predominant GIT malignant 
tumor in children is NHL of the distal small 
bowel and the caecum
7
. The distribution of 
our cases is consistent with this fact as it 
was seen in 42 of our 46 cases (91%); this 
was also reported in other series
8
. In our 
study we had 2 cases of pediatric gastric 
lymphoma, which is compatible with other 
studies. As known, patients with Burkitt’s 
NHL in North Africa and the Middle East 
(including Iran) appear to have a spectrum 
of organ involvement that more closely 
approximate that of sporadic rather than 
endemic form of the disease, since most 
patients present with abdominal tumor 
9
.Large proportion of patients with sporadic 
form of Burkitt’s NHL would present with 
abdominal pain, as in our study 85% of the 
patients had abdominal pain. About ¼ of 
such patients may come with a right iliac 
fossa mass
10
;similarly, a routine pattern of 
clinical presentation was reported in our 
series (Table 2). The distribution of cases 
among different stages in the present study 




The survival results of our study support 
several conclusions determining the 
appropriate role of surgical intervention in 
pediatric gastrointestinal NHL. 
Although, localized disease, complete 
resection, earlier stage (stage II) and 
response to chemotherapy had significantly 
affected the overall survival, the strongest 
predictor of disease-free survival was tumor 
stage at diagnosis, as measured by extent of 
abdominal disease. This is consistent with 
other studies clearly showing that the 
outcome is mostly dependent on the number 
of malignant cells present at initiation of 
therapy
5, 8, 11
,and can be predicted by 
measurement of serum LDH, interleukin II 
and B2 microglobulin levels
9
.Since children 
with partially resected or biopsied tumors 
are treated identically according to the 
extent of disease, partial resections neither 
add to survival, nor prevent the patients 
from entering the higher risk group. Thus, in 
patients in whom complete resection is 
impossible, have no evidence of extra-
abdominal extension and laparotomy is 
needed for diagnosis, surgery should be 
limited only to the least invasive procedure, 
such as biopsy or a simple intestinal 
resection-anastomosis. This is to avoid any 
major surgical procedure that may lead to 
higher incidence of postoperative 
complications and more importantly may 
lead to delay in initiation of chemotherapy. 
In a large review, patients with pediatric 
gastric lymphoma had the same 5-year 
survival rate irrespective of whether the 
primary tumor was resected or not 
12
.Nowadays fine needle aspiration cytology 
can be helpful in diagnosis of abdominal and 




Earlier reports about results of treatment 
showed overall survival results ranging from 
60% to 65%
5
.The disease free survival in 
patients with localized disease was reported 
to be 85% 
10
.The results of several new 
protocol in which the principles of risk 
stratification is being used, show better 
results with overall disease free survival of 
approximately 90%; and patients with stage 
II have 98-100% disease free survival rate 
versus 76% in those with extensive disease 
14, 15
. In our study overall survival results 
was 85% which considering its small sample 
size and different applied chemotherapy 
protocols can be more or less considered 
close to other reports in this regard. We had 
7cases of mortality (3 in the debulking 
group and 4 cases in the biopsy group) no 
mortality was seen in localized tumors. 
 






The extent ofdisease at presentation is the 
most important prognostic factor in 
abdominal Burkitt lymphoma. Children with 
Burkitt lymphoma are at high risks of tumor 
lysis syndrome before or during 
chemotherapy. Surgery still plays an 
important role in this pathology, and 
chemotherapy offers an excellent chance for 
long term disease free survival. 
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